# FDA Inspection 1158618 - Paul E. Ziajka, M.D., Ph.D. - December 06, 2021

Source: https://www.keypedia.com/records/fda_inspections/paul-e-ziajka-md-phd/1f9a0327-39e4-4687-89f6-fbbd3304461a
Source feed: FDA_Inspections

> FDA Inspection 1158618 for Paul E. Ziajka, M.D., Ph.D. on December 06, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1158618
- Company Name: Paul E. Ziajka, M.D., Ph.D.
- Inspection Date: 2021-12-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/paul-e-ziajka-md-phd/31f37e71-ce51-4e28-af2b-994319002df5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c